Table 3 Features of papers for the meta-analysis of 5-year survival in cancers
From: Prognostic significance of long non-coding RNA five prime to XIST in various cancers
Trial. | Year | High expression | Low expression | Cases | Outcomes | Cancer type | Follow-up | ||
|---|---|---|---|---|---|---|---|---|---|
Death | 5-year survival | Death | 5-year survival | ||||||
Liang et al. | 2020 | 86 | 9 | 64 | 28 | > 100 | OS | Glioma | 60 |
2020 | 93 | 2 | 73 | 19 | > 100 | PFS | Glioma | 60 | |
Zhang et al. | 2020 | 26 | 6 | 20 | 19 | < 100 | OS | Glioma | 60 |
Vasquez et al. | 2019 | 81 | 190 | 56 | 216 | > 100 | OS | Others | 60 |
Li et al. | 2018 | 30 | 9 | 18 | 27 | < 100 | OS | Osteosarcoma | 60 |
Yang et al. | 2018 | 30 | 10 | 30 | 10 | < 100 | OS | Osteosarcoma | 60 |
Liu et al. | 2016 | 53 | 12 | 31 | 30 | > 100 | OS | Colorectal cancer | 60 |
2016 | 59 | 6 | 37 | 24 | > 100 | DFS | Colorectal cancer | 60 | |
Liu et al. | 2016 | 32 | 32 | 45 | 20 | > 100 | OS | Others | 60 |
2016 | 32 | 32 | 52 | 13 | > 100 | RFS | Hepatocellular carcinoma | 60 | |
Guo et al. | 2015 | 62 | 13 | 87 | 25 | > 100 | OS | Colorectal cancer | 60 |
2015 | 38 | 37 | 45 | 67 | > 100 | RFS | Colorectal cancer | 60 | |